PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 2, 2025Journal of Clinical Medicine7 citationsOpen Access

Conservative Surgical Management of Adenomyosis: Implications for Infertility and Pregnancy Outcomes—A Perspective Review

View Full Paper
AIAlexandra IoannidouKLKonstantinos LouisDSDimos Sioutis

Key Points

  • Conservative surgery for adenomyosis can enhance fertility in select women, especially those with focal disease.
  • Adenomyomectomy shows pregnancy rates exceeding 50% and live birth rates up to 70% in focal cases.
  • Non-excisional techniques like HIFU and RFA report comparable pregnancy rates of 40-53% in selected patients.
  • Standardized patient selection criteria and adjunctive hormonal therapy may optimize surgical outcomes.

Abstract

Background/Objectives: Adenomyosis is increasingly being identified in women of childbearing age as a cause of infertility and adverse pregnancy outcomes. As hysterectomies are not suitable for fertile women, conservative surgical management has become a promising solution. We aimed to synthesize current evidence on conservative uterus-sparing surgical techniques for adenomyosis, focusing on implications for infertility treatment and pregnancy outcomes. Methods: A search of PubMed, Google Scholar, and Europe PMC from 2022 to July 2025 was conducted using combinations of the words “adenomyosis,” “fertility,” “infertility,” “pregnancy outcomes,” “adenomyomectomy,” and “uterine-sparing surgery.” Sixteen high-relevance studies were chosen that included reproductive-aged women who had conservative surgery for adenomyosis. Results: Excisional techniques such as adenomyomectomy yield pregnancy rates of >50% and live birth rates of up to 70% in focal disease, with less success in diffuse disease. Non-excisional approaches—high-intensity focused ultrasound (HIFU), radiofrequency ablation (RFA), and uterine artery embolization (UAE)—yield equivalent pregnancy (40–53%) and live birth (35–74%) rates in selected patients, with fewer surgical complications. Adjunctive hormonal therapy, particularly GnRH agonists, appears to improve outcomes. Risks include placenta accreta spectrum disorders and uterine rupture (≤6%), especially in diffuse adenomyosis. The type of lesion, location, and junctional zone thickness are strong predictors of fertility outcomes. Conclusions: Conservative surgery can augment fertility in appropriately chosen women with adenomyosis, with removal being the preferred treatment for focal disease and non-removal techniques offering encouraging alternatives in mild or intracorporeal disease. The addition of adjunct hormonal therapy and standardized patient selection criteria will optimize results. The lack of European professional society guidelines underscores the need for harmonized protocols in order to standardize the diagnosis, surgery, and reporting of results.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ioannidou et al. (2025) studied this question.

synapsesocial.com/papers/68de68e583cbc991d0a20eb8https://doi.org/10.3390/jcm14196956
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Impact of Conservative Surgical Treatment of Adenomyosis on Fertility and Perinatal Outcomes2024 · 12 citations
  2. 2Surgical Treatment of Adenomyosis2024 · 7 citations
  3. 3Case Report: The first case of successful pregnancy and live birth following laparoscopic resection of adenomyosis under real-time intraoperative ultrasound elastography guidance2024 · 3 citations
  4. 4Pregnancy and delivery outcomes in the women who have received adenomyomectomy: Performed by a single surgeon by a uniform surgical technique2021 · 31 citations
  5. 5Clinical investigation of fertility after uterine artery embolization2021 · 56 citations